Drug General Information
| Drug Name |
Derazantinib
|
||
| Synonyms |
Derazantinib
|
||
| Drug Type |
Small molecular drug
|
||
| Company |
NA
|
||
| Summary |
Derazantinib is under investigation in clinical trial NCT03230318 (Derazantinib in Subjects With FGFR2 Gene Fusion Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma).
|
||
Drug Chemical Infomation and External Links
|
Formula |
C29H29FN4O
|
| Canonical SMILES |
COCCNCCC1=CC(NC2=NC=C3C[C@@H](C4=CC=CC=C4F)C4=CC=CC=C4C3=N2)=CC=C1
|
|
| InChI |
1S/C29H29FN4O/c1-35-16-15-31-14-13-20-7-6-8-22(17-20)33-29-32-19-21-18-26(24-10-4-5-12-27(24)30)23-9-2-3-11-25(23)28(21)34-29/h2-12,17,19,26,31H,13-16,18H2,1H3,(H,32,33,34)/t26-/m1/s1
|
|
| InChIKey |
KPJDVVCDVBFRMU-AREMUKBSSA-N
|
|
| CAS Number | CAS 1234356-69-4 | |
| TTD ID | NA | |
| DrugBank ID | DB14889 | |
| PubChem Compound ID | NA | |
| PubChem Substance ID |
NA
|
|
| ChEBI ID | NA | |
| ADReCS Drug ID | NA |
Drug-Food (Herb) Interactions
- Drug
- Foods
- Herbs
- Positive
- Negative
- Possible
- Harmful
- No Effect
| ID | Name | Dose | Type | Drug Brand Name | Drug Dose | Drug Dosage Form | Experimental Species | Individuals Number | Test Sample | Ingredient | Effect | Relationship Classification | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ID | Name | Dose | Type | Drug Brand Name | Drug Dose | Drug Dosage Form | Experimental Species | Individuals Number | Test Sample | Ingredient | Effect | Relationship classification |